|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/69 | |
| C07F 5/02 | |||
| A61K 45/06 | |||
| A61P 31/04 |
| (11) | Number of the document | 2928898 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13861198.3 |
| Date of filing the European patent application | 2013-12-05 | |
| (97) | Date of publication of the European application | 2015-10-14 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-14 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2013/073428 |
| Date | 2013-12-05 |
| (87) | Number | WO 2014/089365 |
| Date | 2014-06-12 |
| (30) | Number | Date | Country code |
| 201261734900 P | 2012-12-07 | US | |
| 201361783238 P | 2013-03-14 | US |
| (72) |
BURNS, Christopher, J., US
DAIGLE, Denis, US
LIU, Bin, US
MCGARRY, Daniel, US
PEVEAR, Daniel C., US
TROUT, Robert E. Lee, US
|
| (73) |
Venatorx Pharmaceuticals, Inc.,
30 Spring Mill Drive, Malvern, PA 19355,
US
|
| (54) | BETA-LACTAMASE INHIBITORS |
| BETA-LACTAMASE INHIBITORS |